Paper34237694
Effects of probiotic supplementation on anthropometric and metabolic characteristics in adults with metabolic syndrome: A systematic review and meta-analysis of randomized clinical trials.
Hadi A and 5 others. Clin Nutr, 2021. Cited by 38 papers, by iCite.
Cite this record
ConductScience Library. Effects of probiotic supplementation on anthropometric and metabolic characteristics in adults with metabolic syndrome: A systematic review and meta-analysis of randomized clinical trials. Papers, record 34237694. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34237694
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of probiotic supplementation on anthropometric and metabolic characteristics in adults with metabolic syndrome: A systematic review and meta-analysis of randomized clinical trials.
- PubMed
- Publication types
- Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Metabolic Syndrome | Major topic |
| Probiotics | Major topic |
| Synbiotics | Major topic |
| Adult | |
| Anthropometry | |
| Body Mass Index | |
| Cholesterol | |
| Cholesterol, HDL | |
| Cholesterol, LDL | |
| Female | |
| Humans | |
| Insulin | |
| Insulin Resistance | |
| Male | |
| Middle Aged | |
| Randomized Controlled Trials as Topic | |
| Triglycerides | |
| Waist Circumference |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 35000768 | Effects of probiotic supplementation on anthropometric and metabolic characteristics in adults with metabolic syndrome: Letter to the editor. | https://conductscience.org/library/papers/35000768 |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 38 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42959927 | Integrating preclinical and clinical evidence: a meta-analysis of probiotic/synbiotic interventions on metabolic syndrome. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42959927 | PubMed |
| 42890809 | Probiotics-derived postbiotics improve host metabolic syndrome by activating the adipocyte thermogenic signaling pathway in high-fat diet-fed mice. | IMetaOmics | 2026 | https://conductscience.org/library/papers/42890809 | PubMed |
| 42510662 | Gut Microbiota and Metabolic Syndrome: A Narrative Review. | Biology (Basel) | 2026 | https://conductscience.org/library/papers/42510662 | PubMed |
| 42072163 | Microbiota-Gut-Brain Axis Disruption, Neuroinflammation, and Potential Antioxidant-Based Treatments in Metabolic Diseases. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42072163 | PubMed |
| 41837402 | Effects of propolis supplementation on blood glucose and lipid profiles in individuals with metabolic syndrome and type 2 diabetes: a systematic review and meta-analysis. | Clin Nutr Res | 2026 | https://conductscience.org/library/papers/41837402 | PubMed |
| 41767366 | Propolis Supplementation and Metabolic Syndrome Components in Adults at Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/41767366 | PubMed |
| 41524907 | A multifaceted lifestyle program for weight loss in overweight adults: evidence from a randomised clinical trial. | Eur J Nutr | 2026 | https://conductscience.org/library/papers/41524907 | PubMed |
| 41366011 | Innovative formulation of microencapsulated "spirubiotic sachets" as a synbiotic treatment for metabolic syndrome patients. | Sci Rep | 2025 | https://conductscience.org/library/papers/41366011 | PubMed |
| 40332670 | Updated Insights into Probiotic Interventions for Metabolic Syndrome: Mechanisms and Evidence. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/40332670 | PubMed |
| 40212162 | The impact of gut microbiome modulation on anthropometric indices in metabolic syndrome: an umbrella review. | Ann Med Surg (Lond) | 2025 | https://conductscience.org/library/papers/40212162 | PubMed |
| 39997751 | Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management. | Metabolites | 2025 | https://conductscience.org/library/papers/39997751 | PubMed |
| 39944116 | The effect of probiotics, prebiotics and synbiotics on gut microbial community profile in overweight and obese Latin American and Caribbean populations: a systematic review of human trials. | Gut Microbiome (Camb) | 2025 | https://conductscience.org/library/papers/39944116 | PubMed |
| 39139924 | Association between monosodium glutamate consumption with changes in gut microbiota and related metabolic dysbiosis-A systematic review. | Food Sci Nutr | 2024 | https://conductscience.org/library/papers/39139924 | PubMed |
| 39055191 | Appetite sensation improvement by synbiotic supplementation in patients with metabolic syndrome: A randomized controlled clinical trial. | Food Sci Nutr | 2024 | https://conductscience.org/library/papers/39055191 | PubMed |
| 38977065 | Is There Evidence to Support Probiotic Use for Healthy People? | Adv Nutr | 2024 | https://conductscience.org/library/papers/38977065 | PubMed |
| 38260154 | Effect of supplementation with probiotics or synbiotics on cardiovascular risk factors in patients with metabolic syndrome: a systematic review and meta-analysis of randomized clinical trials. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/38260154 | PubMed |
| 38004665 | Prebiotics, Probiotics, and Synbiotics-A Research Hotspot for Pediatric Obesity. | Microorganisms | 2023 | https://conductscience.org/library/papers/38004665 | PubMed |
| 37085813 | Effects of probiotic/synbiotic supplementation on body weight in patients with diabetes: a systematic review and meta-analyses of randomized-controlled trials. | BMC Endocr Disord | 2023 | https://conductscience.org/library/papers/37085813 | PubMed |
| 36908920 | Effects of synbiotics supplementation on anthropometric and lipid profile parameters: Finding from an umbrella meta-analysis. | Front Nutr | 2023 | https://conductscience.org/library/papers/36908920 | PubMed |
| 36781602 | Effects of Probiotic and Selenium Co-supplementation on Lipid Profile and Glycemia Indices: A Systematic Review and Meta-analysis of Randomized Clinical Trials. | Curr Nutr Rep | 2023 | https://conductscience.org/library/papers/36781602 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34237694
GET https://conductscience.org/api/papers/v1/34237694/cited_by?page=2